Enhancing the efficacy of viral vector blood-stage malaria vaccines
<p>Replication-deficient adenovirus (Ad) and modified vaccinia virus Ankara (MVA) vectors expressing single Plasmodium falciparum antigens can induce potent T cell and antibody responses and have entered clinical testing using a heterologous prime-boost immunisation approach (Ad_MVA). This the...
Hoofdauteur: | Forbes, E |
---|---|
Andere auteurs: | Hill, A |
Formaat: | Thesis |
Taal: | English |
Gepubliceerd in: |
2011
|
Onderwerpen: |
Gelijkaardige items
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
door: Kapulu, MC
Gepubliceerd in: (2014) -
Developing novel blood-stage malaria vaccines
door: Douglas, AD
Gepubliceerd in: (2015) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
door: Bauza, K
Gepubliceerd in: (2012) -
Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
door: de Cassan, S
Gepubliceerd in: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
door: Elias, SC
Gepubliceerd in: (2014)